Home Applications 219285 Application 219285
Type NDA
Sponsor GENENTECH INC Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 EVRYSDI RISDIPLAM TABLET;ORAL 5MG Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N219285-001 EVRYSDI RISDIPLAM 5MG TABLET / ORAL RLD, RS 2025-02-11
Orange Book patents# Current patent rows page 1 of 1 · 6 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N219285-001 9586955 2033-02-08 Drug substance, Drug product 2025-03-05 N219285-001 9969754 2035-05-11 U-1943 Drug substance, Drug product 2025-03-05 N219285-001 11827646 2036-01-25 U-1943 2025-03-05 N219285-001 12350273 2038-10-01 U-1943 2025-07-31 N219285-001 11534444 2038-10-04 U-1943 2025-03-05 N219285-001 12122789 2041-04-15 Drug substance, Drug product 2025-03-05
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 1 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N219285-001 M-270 2026-10-03
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N219285-001 EVRYSDI 5MG TABLET / ORAL RLD, RS 2025-02-11 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219285-001 EVRYSDI 5MG TABLET / ORAL RLD, RS 2025-02-11 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N219285-001 EVRYSDI 5MG TABLET / ORAL RLD, RS 2025-02-11 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N219285-001 EVRYSDI 5MG TABLET / ORAL RLD, RS 2025-02-11 fd3edfee7708…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219285-001 EVRYSDI 5MG TABLET / ORAL RLD, RS 2025-02-11 a50c72e98297…
Observed Orange Book patent history# Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N219285-001 9586955 2033-02-08 Drug substance, Drug product 2025-03-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219285-001 9969754 2035-05-11 U-1943 Drug substance, Drug product 2025-03-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219285-001 11827646 2036-01-25 U-1943 2025-03-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219285-001 12350273 2038-10-01 U-1943 2025-07-31 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219285-001 11534444 2038-10-04 U-1943 2025-03-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219285-001 12122789 2041-04-15 Drug substance, Drug product 2025-03-05 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219285-001 9586955 2033-02-08 Drug substance, Drug product 2025-03-05 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219285-001 9969754 2035-05-11 U-1943 Drug substance, Drug product 2025-03-05 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219285-001 11827646 2036-01-25 U-1943 2025-03-05 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219285-001 12350273 2038-10-01 U-1943 2025-07-31 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219285-001 11534444 2038-10-04 U-1943 2025-03-05 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219285-001 12122789 2041-04-15 Drug substance, Drug product 2025-03-05 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N219285-001 9586955 2033-02-08 Drug substance, Drug product 2025-03-05 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N219285-001 9969754 2035-05-11 U-1943 Drug substance, Drug product 2025-03-05 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N219285-001 11827646 2036-01-25 U-1943 2025-03-05 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N219285-001 12350273 2038-10-01 U-1943 2025-07-31 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N219285-001 11534444 2038-10-04 U-1943 2025-03-05 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N219285-001 12122789 2041-04-15 Drug substance, Drug product 2025-03-05 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N219285-001 9586955 2033-02-08 Drug substance, Drug product 2025-03-05 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N219285-001 9969754 2035-05-11 U-1943 Drug substance, Drug product 2025-03-05 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N219285-001 11827646 2036-01-25 U-1943 2025-03-05 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N219285-001 11534444 2038-10-04 U-1943 2025-03-05 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N219285-001 12122789 2041-04-15 Drug substance, Drug product 2025-03-05 fd3edfee7708…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219285-001 9586955 2033-02-08 Drug substance, Drug product 2025-03-05 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219285-001 9969754 2035-05-11 U-1943 Drug substance, Drug product 2025-03-05 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219285-001 11827646 2036-01-25 U-1943 2025-03-05 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219285-001 12350273 2038-10-01 U-1943 2025-07-31 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219285-001 11534444 2038-10-04 U-1943 2025-03-05 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219285-001 12122789 2041-04-15 Drug substance, Drug product 2025-03-05 a50c72e98297…
Observed Orange Book exclusivity history# Captured, Edition, Application-product table Captured Edition Application-product Exclusivity code Expiration Source SHA-256 2026-02-19 14:30 UTC 2026-02 N219285-001 M-270 2026-10-03 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219285-001 NCE 2025-08-07 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219285-001 M-270 2026-10-03 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N219285-001 NCE 2025-08-07 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N219285-001 M-270 2026-10-03 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N219285-001 NCE 2025-08-07 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N219285-001 M-270 2026-10-03 fd3edfee7708…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219285-001 M-270 2026-10-03 a50c72e98297…
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Documents# Document, Submission type, Date table Document Submission type Date 85092 SUPPL 2026-02-20 85091 SUPPL 2026-02-20 84826 SUPPL 2026-01-22 84820 SUPPL 2026-01-22 83388 ORIG 2025-09-19 81249 ORIG 2025-02-14 81233 ORIG 2025-02-12